Abstract
The ε4 allele of APOE is generally accepted to be a risk factor in Alzheimer's disease and it has been related to other neuropsychiatric disorders, including schizophrenia. The results of several case-control studies have been inconclusive. To shed more light on this issue we carried out an association study that compared the APOE common variant in a group of 365 schizophrenia patients and 584 controls. We found no differences in the genotype distributions and allele frequencies of patients and controls. In the group of patients, we also analysed the possible influence of the ε4 allele in the clinical variables. The most important findings are that the age at onset (AAO) of ε4+ schizophrenic women, those that have one or two ε4 alleles, is 4 years earlier than that of ε4− women and their risk of suffering a negative syndrome subtype is four times greater. This was not found in schizophrenic men. Our results show that the APOE variant is not a risk factor for developing schizophrenia but that it may modulate its phenotypic expression in a sex-dependent manner.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mahley RW . Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 1988 240: 622–630
Weisgraber KH, Roses AD, Strittmatter WJ . The role of apolipoprotein E in the nervous system Curr Opin Lipidol 1994 5: 110–116
Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Hajian H, Finch CE . Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro Exp Neurol 1997 143: 313–318
Srivastava RA, Bhasin N, Srivastava N . Apolipoprotein E gene expression in various tissues of mouse and regulation by estrogen Biochem Mol Biol Int 1996 38: 91–101
Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH et al. Association of apolipoprotein E allele ε4 with late onset familial and sporadic Alzheimer's disease Neurology 1993 43: 1467–1472
Corder EH, Saunders AM, Strittmatter WJ, Schmechel D, Gaskell PC, Small GW et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 1993 261: 921–923
Harrington CR, Roth M, Xuereb JH, McKenna PJ, Wischik CM . Apolipoprotein E type ε4 allele frequency is increased in patients with schizophrenia Neurosci Lett 1995 202: 101–104
Jönsson E, Lannfelt L, Engvall B, Sedvall G . Lack of association between schizophrenia and the apolipoprotein E ε4 allele Eur Arch Psychiatry Clin Neurosci 1996 246: 1182–1184
Zhu S, Nöthen MM, Uhlhaas S, Rietschel M, Körner J, Lanczik M et al. Apolipoprotein E genotype distribution in schizophrenia Psychiatr Genet 1996 6: 75–79
Arnold SE, Joo E, Martinoli MG, Roy N, Trojanowski JQ, Gur RE et al. Apolipoprotein E genotype in schizophrenia: frequency, age of onset, and neuropathologic features Neuroreport 1997 8: 1523–1526
Kimura T, Yokota S, Igata-Yi R, Shono M, Takamatsu J, Miyakawa T . Apolipoprotein E ε4 allele and schizophrenia Neurosci Lett 1997 231: 53–55
Powchik P, Friedman J, Haroutunian V, Greenberg D, Altsteil L, Purohit D et al. Apolipoprotein E4 in schizophrenia: a study of one hundred sixteen cases with neuropathological examination Biol Psychiatry 1997 42: 296–298
Thibaut F, Coron B, Hannequin D, Segard L, Martin C, Dollfus S et al. No association of apolipoprotein epsilon 4 allele with schizophrenia even in cognitively impaired patients Schizophr Res 1998 30: 149–153
Sorbi S, Nacmias B, Tedde A, Latorraca S, Forleo P, Guarnieri BM et al. No implication of apolipoprotein E polymorphism in Italian schizophrenic patients Neurosci Lett 1998 244: 118–120
Thibaut F, Van der Elst A, Campion D, Martin C, Coron B, Dollfus S et al. Apolipoprotein E-ε4 frequency in deficit schizophrenia Eur Psychiat 1999 14: 148–151
Chen J-Y, Hong C-J, Chiu H-J, Lin C-Y, Bai Y-M, Song H-L et al. Apolipoprotein E genotype and schizophrenia Neuropsychobiology 1999 39: 141–143
Igata-Yi R, Igata T, Ishizuka K, Kimura T, Sakamoto S, Katsuragi S et al. Apolipoprotein E genotype and psychosis Biol Psychiatry 1997 41: 906–908
Pickar D, Malhotra AK, Rooney W, Breier A, Goldman D . Apolipoprotein E ε4 and clinical phenotype in schizophrenia Lancet 1997 350: 930–931
Rietschel M, Krauβ H, Müller DJ, Nöthen MM, Macciardi F . Apolipoprotein E ε4 and clinical phenotype in schizophrenia Lancet 1997 350: 1857–1858
Salem JE, Kring AM . The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia Clin Psychol Rev 1998 18: 795–819
Farrer LA, Cupples A, Haines JL, Hyman B, Kukull WA, Mayeux R et al. Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis JAMA 1997 278: 1349–1356
Woolley C . Effects of estrogen in the CNS Curr Opin Neurobiol 1999 9: 349–354
Raber J, Wong D, Buttini M, Orth M, Bellosta S, Pitas RE et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in APOE knockout mice: increased susceptibility of females Proc Natl Acad Sci USA 1998 95: 10914–10919
Valero J, Martorell L, Mariné J, Vilella E, Labad A . Anticipation and imprinting in Spanish families with schizophrenia Acta Psychiatr Scand 1998 97: 343–350
Busch H, von Cranach M, Gulbinat W, Renfordt E, Tegeler J . Reliability of the AMDP-system. A preliminary report on a multicentre exercise on the reliability of psychopathological assessment Acta Psychiatr Scand 1980 62: 382–392
Hixson JE, Vernier DT . Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal J Lipid Res 1990 31: 545–548
Sham PC, Curtis D . Monte Carlo tests for associations between disease and alleles at highly polymorphic loci Ann Hum Genet 1995 59: 97–105
Acknowledgements
This work was supported in part by grant FIS 98/1433. Carmen Virgos is a predoctoral fellow financed by the Comissionat per a Universitats i Recerca.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martorell, L., Virgos, C., Valero, J. et al. Schizophrenic women with the APOE ε4 allele have a worse prognosis than those without it. Mol Psychiatry 6, 307–310 (2001). https://doi.org/10.1038/sj.mp.4000855
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000855
Keywords
This article is cited by
-
Association between clinical symptoms and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia
Annals of General Psychiatry (2021)
-
Apolipoprotein E polymorphism is associated with age of onset in schizophrenia
Journal of Human Genetics (2004)